$2.29+0.21 (+9.83%)
News25/Ratings0
Price$2.29+0.10 (+4.81%)
01:45 PM07:45 PM
News · 26 weeks25-50%
2025-10-262026-04-19
Mix1490d
- SEC Filings6(43%)
- Other5(36%)
- Insider3(21%)
Latest news
25 items- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form D filed by Firefly Neuroscience Inc.D - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- PRWith Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World's First Known 200,000+ Standardized EEG/ERP Depository- Firefly's total brain scan volumes have increased sequentially by higher percentages in each of the past four quarters - - Firefly is harnessing increased data and NVIDIA L40S GPU acceleration to power next-generation EEG/ERP processing, enabling new AI-driven biomarker discovery capabilities – - Milestone supports Firefly's goal of building and launching the world's first EEG/ERP-based foundation model of the human brain - KENMORE, N.Y., April 13, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and
- SECSEC Form 10-K filed by Firefly Neuroscience Inc.10-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- PRFirefly Confirms Public-Private Partnership with the Department of WarFirefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service Members Partnership Represents a Significant Expansion of Company's Commercial Footprint into the U.S. Government and Defense Health Sectors KENMORE, N.Y., March 26, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (NASDAQ:AIFF) ("Firefly," or the "Company"), today announced a partnership with the Department of War ("DoW") to support the assessment and treatment of active-duty U.S. service members and veterans suffering from Post-Traumatic Stress Disorder ("PTSD") and/or Traumatic Brain Injury ("TBI"). The genesis of this innovative public-private
- INSIDERAmendment: New insider Lipschitz Gregory claimed ownership of 403,707 shares (SEC Form 3)3/A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- PRFirefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHDOver 22 million Americans are diagnosed with ADHD — yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1 Firefly's AI-powered EEG/ERP technology may help identify which ADHD subtype a patient has — potentially complementing subjective symptom checklists with neural signal-based precision Subtype identification could change the clinical equation: Firefly's platform may help clinicians determine the most appropriate treatment type, inform dosage decisions, and potentially monitor whether an intervention is working The breakthrough advances Firefly's mission to build the world's first EEG/ERP brain foundation model — bein
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- INSIDERPresident and COO Decaprio David was granted 44,872 shares, increasing direct ownership by 136% to 77,866 units (SEC Form 4)4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- INSIDERChief Executive Officer Lipschitz Gregory was granted 65,988 shares, increasing direct ownership by 14% to 530,184 units (SEC Form 4)4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- PRAnxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar ExpansionGAD Therapies Market Set to Explode to $4.26B by 2033 as Demand Rockets for Innovative Anxiety Solutions NEW YORK, March 5, 2026 /CNW/ -- Market News Updates News Commentary - Treatments for Generalized Anxiety Disorder (GAD) are getting better and more accessible, which is good news for millions of people dealing with constant worry and stress. Traditional medications like anti-anxiety drugs and antidepressants still play a big role, but therapy options such as cognitive-behavioral therapy and mindfulness techniques are also helping people manage symptoms without relying only on medication. Digital mental health tools and telehealth visits are making treatment easier to access, especially f
- PRFirefly Progresses Toward Development and Commercial Launch of its Foundation Model of the Human Brain Powered by NVIDIA GPU Acceleration- Company reports 20-fold expansion of commercial footprint, 33-fold increase in EEG/ERP brain scan volumes - - Harnessing increased data and cutting-edge supercomputing potentially unlocks new AI-driven biomarker discovery capabilities and significantly advances Firefly on its path of building a foundation model of the human brain - KENMORE, N.Y., March 04, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announce a greater than 20-fold expansion of its commercial f
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form 424B5 filed by Firefly Neuroscience Inc.424B5 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form EFFECT filed by Firefly Neuroscience Inc.EFFECT - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form S-3 filed by Firefly Neuroscience Inc.S-3 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECSEC Form S-8 filed by Firefly Neuroscience Inc.S-8 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- PRFirefly Neuroscience Reports Third Quarter 2025 Financial Results– Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line – – Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP scan volumes and 30% sequential revenue growth – KENMORE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today reported financial results for the three and nine months ended September 30, 2025. Business Highlights Third quarter 2025 revenue grew more than tenfold year-over-year and 30% s
- SECSEC Form 10-Q filed by Firefly Neuroscience Inc.10-Q - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Firefly Neuroscience Inc.SCHEDULE 13D/A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)
- SECFirefly Neuroscience Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
- INSIDERSEC Form 4 filed by Director Menawat Arun Swarup4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- INSIDERSEC Form 4 filed by Director Posner Brian M4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)
- INSIDERSEC Form 4 filed by Director Vnook Stella4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)